I checked to confirm if we are likely to do our manufacturing at...

I checked to confirm if we are likely to do our manufacturing at Peter Mac and it certainly appears that way.

https://www.petermac.org/news/milestone-australia-s-first-t-cell-therapy-manufacturing-license-awarded August 29, 2019

Peter MacCallum Cancer Centre welcomes the issuing of the first license to manufacture commercial T-Cell treatments, including breakthrough CAR T-Cell therapies, within Australia. The Therapeutic Goods Administration has awarded a T-Cells GMP manufacturing licence to Cell Therapies Pty Ltd, a company which is situated at Peter Mac.

I don't think we can underestimate the partnership we have Peter Mac and the ongoing support and fantastic position it puts Prescient. The following is Peter Mac's specialty division "Cell Therapies"

https://www.petermac.org/about/partnerships/cell-therapies

What's your take on the role that Peter Mac is likely to play in our monetization of Cell Pryme? I would imagine that we would need some sort contractural agreement of sort with Peter Mac. I can't imagine Peter Mac not wanting to use our cell manufacturing technology given its superirity, do you?

PS: I reckon @Un1qu3Nam3 deserves the Freddo Frog for Cell Pryme - A being the "Application" part of the equation. And, I reckon Steve enjoyed dangling that one out there for us as a bit of a guessing game.